nodes	percent_of_prediction	percent_of_DWPC	metapath
Norethindrone—PGR—Betamethasone—psoriatic arthritis	0.105	0.234	CbGbCtD
Norethindrone—ALB—Auranofin—psoriatic arthritis	0.0698	0.156	CbGbCtD
Norethindrone—PGR—Dexamethasone—psoriatic arthritis	0.0609	0.136	CbGbCtD
Norethindrone—Danazol—Prednisone—psoriatic arthritis	0.0356	0.0755	CrCrCtD
Norethindrone—Cortisone acetate—Methylprednisolone—psoriatic arthritis	0.0329	0.0698	CrCrCtD
Norethindrone—Cortisone acetate—Prednisone—psoriatic arthritis	0.03	0.0637	CrCrCtD
Norethindrone—Cortisone acetate—Prednisolone—psoriatic arthritis	0.0293	0.0622	CrCrCtD
Norethindrone—Fluoxymesterone—Betamethasone—psoriatic arthritis	0.0289	0.0612	CrCrCtD
Norethindrone—Fluoxymesterone—Dexamethasone—psoriatic arthritis	0.0289	0.0612	CrCrCtD
Norethindrone—Fluoxymesterone—Triamcinolone—psoriatic arthritis	0.0282	0.0598	CrCrCtD
Norethindrone—Fluoxymesterone—Prednisolone—psoriatic arthritis	0.0261	0.0554	CrCrCtD
Norethindrone—Progesterone—Prednisolone—psoriatic arthritis	0.0254	0.054	CrCrCtD
Norethindrone—Methyltestosterone—Prednisone—psoriatic arthritis	0.0254	0.0539	CrCrCtD
Norethindrone—Methyltestosterone—Prednisolone—psoriatic arthritis	0.0248	0.0526	CrCrCtD
Norethindrone—Hydrocortisone—Methylprednisolone—psoriatic arthritis	0.0233	0.0494	CrCrCtD
Norethindrone—Hydrocortisone—Betamethasone—psoriatic arthritis	0.0229	0.0487	CrCrCtD
Norethindrone—Hydrocortisone—Dexamethasone—psoriatic arthritis	0.0229	0.0487	CrCrCtD
Norethindrone—Hydrocortisone—Triamcinolone—psoriatic arthritis	0.0224	0.0475	CrCrCtD
Norethindrone—ALB—Prednisone—psoriatic arthritis	0.0222	0.0495	CbGbCtD
Norethindrone—Testosterone—Prednisolone—psoriatic arthritis	0.0221	0.0469	CrCrCtD
Norethindrone—Hydrocortisone—Prednisone—psoriatic arthritis	0.0213	0.0451	CrCrCtD
Norethindrone—Hydrocortisone—Prednisolone—psoriatic arthritis	0.0208	0.044	CrCrCtD
Norethindrone—ABCB1—Methylprednisolone—psoriatic arthritis	0.0192	0.0428	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0148	0.0331	CbGbCtD
Norethindrone—CYP3A7—Dexamethasone—psoriatic arthritis	0.0148	0.0331	CbGbCtD
Norethindrone—CYP2C19—Prednisone—psoriatic arthritis	0.0144	0.0321	CbGbCtD
Norethindrone—ABCB1—Betamethasone—psoriatic arthritis	0.0125	0.0278	CbGbCtD
Norethindrone—ABCB1—Prednisolone—psoriatic arthritis	0.0123	0.0274	CbGbCtD
Norethindrone—ABCB1—Prednisone—psoriatic arthritis	0.0116	0.0259	CbGbCtD
Norethindrone—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0115	0.0256	CbGbCtD
Norethindrone—CYP3A5—Dexamethasone—psoriatic arthritis	0.0111	0.0249	CbGbCtD
Norethindrone—ALB—Methotrexate—psoriatic arthritis	0.0111	0.0249	CbGbCtD
Norethindrone—CYP2C19—Dexamethasone—psoriatic arthritis	0.00898	0.02	CbGbCtD
Norethindrone—CYP3A4—Triamcinolone—psoriatic arthritis	0.0087	0.0194	CbGbCtD
Norethindrone—CYP3A4—Betamethasone—psoriatic arthritis	0.00747	0.0167	CbGbCtD
Norethindrone—CYP3A4—Prednisolone—psoriatic arthritis	0.00737	0.0164	CbGbCtD
Norethindrone—ABCB1—Dexamethasone—psoriatic arthritis	0.00725	0.0162	CbGbCtD
Norethindrone—CYP3A4—Prednisone—psoriatic arthritis	0.00696	0.0155	CbGbCtD
Norethindrone—ABCB1—Methotrexate—psoriatic arthritis	0.00583	0.013	CbGbCtD
Norethindrone—CYP3A4—Dexamethasone—psoriatic arthritis	0.00434	0.00969	CbGbCtD
Norethindrone—Hirsutism—Betamethasone—psoriatic arthritis	0.00063	0.00781	CcSEcCtD
Norethindrone—Embolism—Triamcinolone—psoriatic arthritis	0.000628	0.00779	CcSEcCtD
Norethindrone—Embolism—Methylprednisolone—psoriatic arthritis	0.000627	0.00778	CcSEcCtD
Norethindrone—Alopecia—Auranofin—psoriatic arthritis	0.000611	0.00757	CcSEcCtD
Norethindrone—Optic neuritis—Dexamethasone—psoriatic arthritis	0.000595	0.00738	CcSEcCtD
Norethindrone—Optic neuritis—Betamethasone—psoriatic arthritis	0.000595	0.00738	CcSEcCtD
Norethindrone—Dermatitis atopic—Prednisolone—psoriatic arthritis	0.000593	0.00735	CcSEcCtD
Norethindrone—Flatulence—Auranofin—psoriatic arthritis	0.000593	0.00735	CcSEcCtD
Norethindrone—Menstruation irregular—Prednisone—psoriatic arthritis	0.000576	0.00714	CcSEcCtD
Norethindrone—Embolism—Betamethasone—psoriatic arthritis	0.00057	0.00707	CcSEcCtD
Norethindrone—Embolism—Dexamethasone—psoriatic arthritis	0.00057	0.00707	CcSEcCtD
Norethindrone—Hirsutism—Prednisone—psoriatic arthritis	0.000548	0.0068	CcSEcCtD
Norethindrone—Dermatitis atopic—Triamcinolone—psoriatic arthritis	0.000545	0.00676	CcSEcCtD
Norethindrone—Acne—Prednisolone—psoriatic arthritis	0.000521	0.00646	CcSEcCtD
Norethindrone—Optic neuritis—Prednisone—psoriatic arthritis	0.000518	0.00643	CcSEcCtD
Norethindrone—Embolism—Prednisone—psoriatic arthritis	0.000497	0.00616	CcSEcCtD
Norethindrone—Acne—Triamcinolone—psoriatic arthritis	0.000479	0.00595	CcSEcCtD
Norethindrone—Acne—Methylprednisolone—psoriatic arthritis	0.000478	0.00593	CcSEcCtD
Norethindrone—Amenorrhoea—Methylprednisolone—psoriatic arthritis	0.000458	0.00568	CcSEcCtD
Norethindrone—Deep vein thrombosis—Methotrexate—psoriatic arthritis	0.000438	0.00543	CcSEcCtD
Norethindrone—Acne—Dexamethasone—psoriatic arthritis	0.000435	0.00539	CcSEcCtD
Norethindrone—Acne—Betamethasone—psoriatic arthritis	0.000435	0.00539	CcSEcCtD
Norethindrone—Dyspepsia—Auranofin—psoriatic arthritis	0.000432	0.00536	CcSEcCtD
Norethindrone—Dermatitis atopic—Prednisone—psoriatic arthritis	0.000431	0.00534	CcSEcCtD
Norethindrone—Amenorrhoea—Dexamethasone—psoriatic arthritis	0.000417	0.00517	CcSEcCtD
Norethindrone—Amenorrhoea—Betamethasone—psoriatic arthritis	0.000417	0.00517	CcSEcCtD
Norethindrone—Embolism—Methotrexate—psoriatic arthritis	0.000415	0.00515	CcSEcCtD
Norethindrone—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.000401	0.00498	CcSEcCtD
Norethindrone—Urticaria—Auranofin—psoriatic arthritis	0.00039	0.00484	CcSEcCtD
Norethindrone—Abdominal pain—Auranofin—psoriatic arthritis	0.000388	0.00481	CcSEcCtD
Norethindrone—Acne—Prednisone—psoriatic arthritis	0.000379	0.0047	CcSEcCtD
Norethindrone—Thrombophlebitis—Prednisolone—psoriatic arthritis	0.000368	0.00456	CcSEcCtD
Norethindrone—Amenorrhoea—Prednisone—psoriatic arthritis	0.000363	0.0045	CcSEcCtD
Norethindrone—Pruritus—Auranofin—psoriatic arthritis	0.000347	0.00431	CcSEcCtD
Norethindrone—Thrombophlebitis—Triamcinolone—psoriatic arthritis	0.000338	0.00419	CcSEcCtD
Norethindrone—Thrombophlebitis—Methylprednisolone—psoriatic arthritis	0.000338	0.00419	CcSEcCtD
Norethindrone—Anaphylactoid reaction—Prednisolone—psoriatic arthritis	0.000329	0.00408	CcSEcCtD
Norethindrone—Affect lability—Prednisolone—psoriatic arthritis	0.000313	0.00389	CcSEcCtD
Norethindrone—Vomiting—Auranofin—psoriatic arthritis	0.000312	0.00387	CcSEcCtD
Norethindrone—Rash—Auranofin—psoriatic arthritis	0.000309	0.00384	CcSEcCtD
Norethindrone—Dermatitis—Auranofin—psoriatic arthritis	0.000309	0.00383	CcSEcCtD
Norethindrone—Thrombophlebitis—Dexamethasone—psoriatic arthritis	0.000307	0.00381	CcSEcCtD
Norethindrone—Thrombophlebitis—Betamethasone—psoriatic arthritis	0.000307	0.00381	CcSEcCtD
Norethindrone—Purpura—Triamcinolone—psoriatic arthritis	0.000304	0.00377	CcSEcCtD
Norethindrone—Anaphylactoid reaction—Triamcinolone—psoriatic arthritis	0.000303	0.00375	CcSEcCtD
Norethindrone—Anaphylactoid reaction—Methylprednisolone—psoriatic arthritis	0.000302	0.00374	CcSEcCtD
Norethindrone—Mood swings—Prednisolone—psoriatic arthritis	0.000302	0.00374	CcSEcCtD
Norethindrone—Nausea—Auranofin—psoriatic arthritis	0.000292	0.00362	CcSEcCtD
Norethindrone—Affect lability—Triamcinolone—psoriatic arthritis	0.000288	0.00357	CcSEcCtD
Norethindrone—Affect lability—Methylprednisolone—psoriatic arthritis	0.000288	0.00357	CcSEcCtD
Norethindrone—Mood swings—Triamcinolone—psoriatic arthritis	0.000277	0.00344	CcSEcCtD
Norethindrone—Abdominal distension—Prednisolone—psoriatic arthritis	0.000277	0.00344	CcSEcCtD
Norethindrone—Mood swings—Methylprednisolone—psoriatic arthritis	0.000277	0.00343	CcSEcCtD
Norethindrone—Anaphylactoid reaction—Dexamethasone—psoriatic arthritis	0.000275	0.0034	CcSEcCtD
Norethindrone—Anaphylactoid reaction—Betamethasone—psoriatic arthritis	0.000275	0.0034	CcSEcCtD
Norethindrone—Thrombophlebitis—Prednisone—psoriatic arthritis	0.000267	0.00331	CcSEcCtD
Norethindrone—Pulmonary embolism—Methotrexate—psoriatic arthritis	0.000266	0.0033	CcSEcCtD
Norethindrone—Breast disorder—Methylprednisolone—psoriatic arthritis	0.000264	0.00327	CcSEcCtD
Norethindrone—Migraine—Dexamethasone—psoriatic arthritis	0.000262	0.00324	CcSEcCtD
Norethindrone—Affect lability—Dexamethasone—psoriatic arthritis	0.000262	0.00324	CcSEcCtD
Norethindrone—Migraine—Betamethasone—psoriatic arthritis	0.000262	0.00324	CcSEcCtD
Norethindrone—Affect lability—Betamethasone—psoriatic arthritis	0.000262	0.00324	CcSEcCtD
Norethindrone—Abdominal distension—Triamcinolone—psoriatic arthritis	0.000255	0.00316	CcSEcCtD
Norethindrone—Abdominal distension—Methylprednisolone—psoriatic arthritis	0.000254	0.00315	CcSEcCtD
Norethindrone—Mood swings—Betamethasone—psoriatic arthritis	0.000252	0.00312	CcSEcCtD
Norethindrone—Mood swings—Dexamethasone—psoriatic arthritis	0.000252	0.00312	CcSEcCtD
Norethindrone—Weight increased—Prednisolone—psoriatic arthritis	0.00025	0.00311	CcSEcCtD
Norethindrone—Acute coronary syndrome—Prednisolone—psoriatic arthritis	0.000242	0.003	CcSEcCtD
Norethindrone—Myocardial infarction—Prednisolone—psoriatic arthritis	0.000241	0.00298	CcSEcCtD
Norethindrone—Purpura—Prednisone—psoriatic arthritis	0.00024	0.00298	CcSEcCtD
Norethindrone—Weight increased—Triamcinolone—psoriatic arthritis	0.00023	0.00286	CcSEcCtD
Norethindrone—Weight increased—Methylprednisolone—psoriatic arthritis	0.00023	0.00285	CcSEcCtD
Norethindrone—Affect lability—Prednisone—psoriatic arthritis	0.000228	0.00282	CcSEcCtD
Norethindrone—Thrombophlebitis—Methotrexate—psoriatic arthritis	0.000223	0.00277	CcSEcCtD
Norethindrone—Acute coronary syndrome—Triamcinolone—psoriatic arthritis	0.000222	0.00276	CcSEcCtD
Norethindrone—Acute coronary syndrome—Methylprednisolone—psoriatic arthritis	0.000222	0.00275	CcSEcCtD
Norethindrone—Haemoglobin—Prednisolone—psoriatic arthritis	0.000221	0.00275	CcSEcCtD
Norethindrone—Myocardial infarction—Triamcinolone—psoriatic arthritis	0.000221	0.00274	CcSEcCtD
Norethindrone—Myocardial infarction—Methylprednisolone—psoriatic arthritis	0.000221	0.00274	CcSEcCtD
Norethindrone—Haemorrhage—Prednisolone—psoriatic arthritis	0.00022	0.00273	CcSEcCtD
Norethindrone—Photosensitivity—Methotrexate—psoriatic arthritis	0.00022	0.00273	CcSEcCtD
Norethindrone—Mood swings—Prednisone—psoriatic arthritis	0.000219	0.00272	CcSEcCtD
Norethindrone—Weight increased—Betamethasone—psoriatic arthritis	0.000209	0.00259	CcSEcCtD
Norethindrone—Weight increased—Dexamethasone—psoriatic arthritis	0.000209	0.00259	CcSEcCtD
Norethindrone—Haemoglobin—Triamcinolone—psoriatic arthritis	0.000204	0.00252	CcSEcCtD
Norethindrone—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.000203	0.00252	CcSEcCtD
Norethindrone—Haemorrhage—Triamcinolone—psoriatic arthritis	0.000203	0.00251	CcSEcCtD
Norethindrone—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.000202	0.00251	CcSEcCtD
Norethindrone—Acute coronary syndrome—Dexamethasone—psoriatic arthritis	0.000202	0.0025	CcSEcCtD
Norethindrone—Acute coronary syndrome—Betamethasone—psoriatic arthritis	0.000202	0.0025	CcSEcCtD
Norethindrone—Abdominal distension—Prednisone—psoriatic arthritis	0.000201	0.0025	CcSEcCtD
Norethindrone—Myocardial infarction—Betamethasone—psoriatic arthritis	0.000201	0.00249	CcSEcCtD
Norethindrone—Myocardial infarction—Dexamethasone—psoriatic arthritis	0.000201	0.00249	CcSEcCtD
Norethindrone—Anaphylactoid reaction—Methotrexate—psoriatic arthritis	0.0002	0.00248	CcSEcCtD
Norethindrone—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.000199	0.00246	CcSEcCtD
Norethindrone—Haemoglobin—Dexamethasone—psoriatic arthritis	0.000185	0.00229	CcSEcCtD
Norethindrone—Haemoglobin—Betamethasone—psoriatic arthritis	0.000185	0.00229	CcSEcCtD
Norethindrone—Haemorrhage—Dexamethasone—psoriatic arthritis	0.000184	0.00228	CcSEcCtD
Norethindrone—Haemorrhage—Betamethasone—psoriatic arthritis	0.000184	0.00228	CcSEcCtD
Norethindrone—Mood swings—Methotrexate—psoriatic arthritis	0.000183	0.00227	CcSEcCtD
Norethindrone—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000183	0.00226	CcSEcCtD
Norethindrone—Weight increased—Prednisone—psoriatic arthritis	0.000182	0.00226	CcSEcCtD
Norethindrone—Depression—Prednisone—psoriatic arthritis	0.000178	0.0022	CcSEcCtD
Norethindrone—Mental disorder—Methylprednisolone—psoriatic arthritis	0.000177	0.0022	CcSEcCtD
Norethindrone—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.000176	0.00218	CcSEcCtD
Norethindrone—Myocardial infarction—Prednisone—psoriatic arthritis	0.000175	0.00217	CcSEcCtD
Norethindrone—Breast disorder—Methotrexate—psoriatic arthritis	0.000175	0.00217	CcSEcCtD
Norethindrone—Convulsion—Prednisolone—psoriatic arthritis	0.000166	0.00206	CcSEcCtD
Norethindrone—Alopecia—Dexamethasone—psoriatic arthritis	0.000162	0.00201	CcSEcCtD
Norethindrone—Alopecia—Betamethasone—psoriatic arthritis	0.000162	0.00201	CcSEcCtD
Norethindrone—Haemoglobin—Prednisone—psoriatic arthritis	0.000161	0.002	CcSEcCtD
Norethindrone—Haemorrhage—Prednisone—psoriatic arthritis	0.00016	0.00199	CcSEcCtD
Norethindrone—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000157	0.00195	CcSEcCtD
Norethindrone—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000157	0.00194	CcSEcCtD
Norethindrone—Oedema—Prednisolone—psoriatic arthritis	0.000157	0.00194	CcSEcCtD
Norethindrone—Convulsion—Triamcinolone—psoriatic arthritis	0.000153	0.00189	CcSEcCtD
Norethindrone—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.000153	0.00189	CcSEcCtD
Norethindrone—Convulsion—Methylprednisolone—psoriatic arthritis	0.000152	0.00189	CcSEcCtD
Norethindrone—Drowsiness—Methotrexate—psoriatic arthritis	0.000149	0.00185	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000149	0.00184	CcSEcCtD
Norethindrone—Depression—Methotrexate—psoriatic arthritis	0.000149	0.00184	CcSEcCtD
Norethindrone—Renal failure—Methotrexate—psoriatic arthritis	0.000146	0.00182	CcSEcCtD
Norethindrone—Immune system disorder—Prednisone—psoriatic arthritis	0.000145	0.00179	CcSEcCtD
Norethindrone—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000144	0.00178	CcSEcCtD
Norethindrone—Oedema—Triamcinolone—psoriatic arthritis	0.000144	0.00178	CcSEcCtD
Norethindrone—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000144	0.00178	CcSEcCtD
Norethindrone—Insomnia—Prednisolone—psoriatic arthritis	0.000142	0.00176	CcSEcCtD
Norethindrone—Alopecia—Prednisone—psoriatic arthritis	0.000141	0.00175	CcSEcCtD
Norethindrone—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000141	0.00175	CcSEcCtD
Norethindrone—Mental disorder—Prednisone—psoriatic arthritis	0.00014	0.00174	CcSEcCtD
Norethindrone—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000139	0.00173	CcSEcCtD
Norethindrone—Convulsion—Dexamethasone—psoriatic arthritis	0.000139	0.00172	CcSEcCtD
Norethindrone—Convulsion—Betamethasone—psoriatic arthritis	0.000139	0.00172	CcSEcCtD
Norethindrone—Haemoglobin—Methotrexate—psoriatic arthritis	0.000134	0.00167	CcSEcCtD
Norethindrone—Hepatitis—Methotrexate—psoriatic arthritis	0.000134	0.00166	CcSEcCtD
Norethindrone—Haemorrhage—Methotrexate—psoriatic arthritis	0.000134	0.00166	CcSEcCtD
Norethindrone—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000131	0.00162	CcSEcCtD
Norethindrone—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000131	0.00162	CcSEcCtD
Norethindrone—Oedema—Betamethasone—psoriatic arthritis	0.000131	0.00162	CcSEcCtD
Norethindrone—Oedema—Dexamethasone—psoriatic arthritis	0.000131	0.00162	CcSEcCtD
Norethindrone—Insomnia—Triamcinolone—psoriatic arthritis	0.00013	0.00161	CcSEcCtD
Norethindrone—Insomnia—Methylprednisolone—psoriatic arthritis	0.00013	0.00161	CcSEcCtD
Norethindrone—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000127	0.00157	CcSEcCtD
Norethindrone—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000126	0.00157	CcSEcCtD
Norethindrone—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000126	0.00157	CcSEcCtD
Norethindrone—Urticaria—Prednisolone—psoriatic arthritis	0.000124	0.00154	CcSEcCtD
Norethindrone—Fatigue—Triamcinolone—psoriatic arthritis	0.000124	0.00154	CcSEcCtD
Norethindrone—Fatigue—Methylprednisolone—psoriatic arthritis	0.000124	0.00154	CcSEcCtD
Norethindrone—Immune system disorder—Methotrexate—psoriatic arthritis	0.000121	0.0015	CcSEcCtD
Norethindrone—Convulsion—Prednisone—psoriatic arthritis	0.000121	0.0015	CcSEcCtD
Norethindrone—Alopecia—Methotrexate—psoriatic arthritis	0.000118	0.00147	CcSEcCtD
Norethindrone—Insomnia—Betamethasone—psoriatic arthritis	0.000118	0.00146	CcSEcCtD
Norethindrone—Insomnia—Dexamethasone—psoriatic arthritis	0.000118	0.00146	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000118	0.00146	CcSEcCtD
Norethindrone—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000117	0.00146	CcSEcCtD
Norethindrone—Mental disorder—Methotrexate—psoriatic arthritis	0.000117	0.00145	CcSEcCtD
Norethindrone—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000115	0.00143	CcSEcCtD
Norethindrone—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000115	0.00143	CcSEcCtD
Norethindrone—Dyspepsia—Betamethasone—psoriatic arthritis	0.000115	0.00143	CcSEcCtD
Norethindrone—Urticaria—Triamcinolone—psoriatic arthritis	0.000114	0.00142	CcSEcCtD
Norethindrone—Urticaria—Methylprednisolone—psoriatic arthritis	0.000114	0.00141	CcSEcCtD
Norethindrone—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000114	0.00141	CcSEcCtD
Norethindrone—Oedema—Prednisone—psoriatic arthritis	0.000114	0.00141	CcSEcCtD
Norethindrone—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000114	0.00141	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000113	0.0014	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000113	0.0014	CcSEcCtD
Norethindrone—Fatigue—Dexamethasone—psoriatic arthritis	0.000113	0.0014	CcSEcCtD
Norethindrone—Fatigue—Betamethasone—psoriatic arthritis	0.000113	0.0014	CcSEcCtD
Norethindrone—Skin disorder—Prednisone—psoriatic arthritis	0.00011	0.00137	CcSEcCtD
Norethindrone—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000107	0.00132	CcSEcCtD
Norethindrone—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000107	0.00132	CcSEcCtD
Norethindrone—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000106	0.00131	CcSEcCtD
Norethindrone—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000106	0.00131	CcSEcCtD
Norethindrone—Urticaria—Betamethasone—psoriatic arthritis	0.000104	0.00129	CcSEcCtD
Norethindrone—Urticaria—Dexamethasone—psoriatic arthritis	0.000104	0.00129	CcSEcCtD
Norethindrone—Dizziness—Prednisolone—psoriatic arthritis	0.000103	0.00128	CcSEcCtD
Norethindrone—Asthenia—Triamcinolone—psoriatic arthritis	0.000103	0.00128	CcSEcCtD
Norethindrone—Abdominal pain—Betamethasone—psoriatic arthritis	0.000103	0.00128	CcSEcCtD
Norethindrone—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000103	0.00128	CcSEcCtD
Norethindrone—Asthenia—Methylprednisolone—psoriatic arthritis	0.000103	0.00128	CcSEcCtD
Norethindrone—Insomnia—Prednisone—psoriatic arthritis	0.000103	0.00128	CcSEcCtD
Norethindrone—Pruritus—Triamcinolone—psoriatic arthritis	0.000102	0.00126	CcSEcCtD
Norethindrone—Pruritus—Methylprednisolone—psoriatic arthritis	0.000102	0.00126	CcSEcCtD
Norethindrone—Convulsion—Methotrexate—psoriatic arthritis	0.000101	0.00125	CcSEcCtD
Norethindrone—Dyspepsia—Prednisone—psoriatic arthritis	0.0001	0.00124	CcSEcCtD
Norethindrone—Rash—Prednisolone—psoriatic arthritis	9.87e-05	0.00122	CcSEcCtD
Norethindrone—Dermatitis—Prednisolone—psoriatic arthritis	9.86e-05	0.00122	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	9.85e-05	0.00122	CcSEcCtD
Norethindrone—Fatigue—Prednisone—psoriatic arthritis	9.81e-05	0.00122	CcSEcCtD
Norethindrone—Headache—Prednisolone—psoriatic arthritis	9.8e-05	0.00122	CcSEcCtD
Norethindrone—Dizziness—Triamcinolone—psoriatic arthritis	9.52e-05	0.00118	CcSEcCtD
Norethindrone—Anaphylactic shock—Methotrexate—psoriatic arthritis	9.5e-05	0.00118	CcSEcCtD
Norethindrone—Dizziness—Methylprednisolone—psoriatic arthritis	9.5e-05	0.00118	CcSEcCtD
Norethindrone—Asthenia—Betamethasone—psoriatic arthritis	9.37e-05	0.00116	CcSEcCtD
Norethindrone—Asthenia—Dexamethasone—psoriatic arthritis	9.37e-05	0.00116	CcSEcCtD
Norethindrone—Gastrointestinal pain—Prednisone—psoriatic arthritis	9.3e-05	0.00115	CcSEcCtD
Norethindrone—Nausea—Prednisolone—psoriatic arthritis	9.3e-05	0.00115	CcSEcCtD
Norethindrone—Pruritus—Betamethasone—psoriatic arthritis	9.24e-05	0.00115	CcSEcCtD
Norethindrone—Pruritus—Dexamethasone—psoriatic arthritis	9.24e-05	0.00115	CcSEcCtD
Norethindrone—Skin disorder—Methotrexate—psoriatic arthritis	9.23e-05	0.00114	CcSEcCtD
Norethindrone—Vomiting—Triamcinolone—psoriatic arthritis	9.15e-05	0.00113	CcSEcCtD
Norethindrone—Vomiting—Methylprednisolone—psoriatic arthritis	9.13e-05	0.00113	CcSEcCtD
Norethindrone—Rash—Triamcinolone—psoriatic arthritis	9.07e-05	0.00113	CcSEcCtD
Norethindrone—Dermatitis—Triamcinolone—psoriatic arthritis	9.07e-05	0.00112	CcSEcCtD
Norethindrone—Rash—Methylprednisolone—psoriatic arthritis	9.05e-05	0.00112	CcSEcCtD
Norethindrone—Dermatitis—Methylprednisolone—psoriatic arthritis	9.05e-05	0.00112	CcSEcCtD
Norethindrone—Urticaria—Prednisone—psoriatic arthritis	9.03e-05	0.00112	CcSEcCtD
Norethindrone—Headache—Triamcinolone—psoriatic arthritis	9.02e-05	0.00112	CcSEcCtD
Norethindrone—Headache—Methylprednisolone—psoriatic arthritis	9e-05	0.00112	CcSEcCtD
Norethindrone—Abdominal pain—Prednisone—psoriatic arthritis	8.99e-05	0.00111	CcSEcCtD
Norethindrone—Dizziness—Betamethasone—psoriatic arthritis	8.64e-05	0.00107	CcSEcCtD
Norethindrone—Dizziness—Dexamethasone—psoriatic arthritis	8.64e-05	0.00107	CcSEcCtD
Norethindrone—Insomnia—Methotrexate—psoriatic arthritis	8.6e-05	0.00107	CcSEcCtD
Norethindrone—Nausea—Triamcinolone—psoriatic arthritis	8.55e-05	0.00106	CcSEcCtD
Norethindrone—Nausea—Methylprednisolone—psoriatic arthritis	8.53e-05	0.00106	CcSEcCtD
Norethindrone—Somnolence—Methotrexate—psoriatic arthritis	8.45e-05	0.00105	CcSEcCtD
Norethindrone—Hypersensitivity—Prednisone—psoriatic arthritis	8.38e-05	0.00104	CcSEcCtD
Norethindrone—Dyspepsia—Methotrexate—psoriatic arthritis	8.37e-05	0.00104	CcSEcCtD
Norethindrone—Vomiting—Betamethasone—psoriatic arthritis	8.3e-05	0.00103	CcSEcCtD
Norethindrone—Vomiting—Dexamethasone—psoriatic arthritis	8.3e-05	0.00103	CcSEcCtD
Norethindrone—Rash—Betamethasone—psoriatic arthritis	8.23e-05	0.00102	CcSEcCtD
Norethindrone—Rash—Dexamethasone—psoriatic arthritis	8.23e-05	0.00102	CcSEcCtD
Norethindrone—Dermatitis—Betamethasone—psoriatic arthritis	8.23e-05	0.00102	CcSEcCtD
Norethindrone—Dermatitis—Dexamethasone—psoriatic arthritis	8.23e-05	0.00102	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	8.21e-05	0.00102	CcSEcCtD
Norethindrone—Fatigue—Methotrexate—psoriatic arthritis	8.19e-05	0.00102	CcSEcCtD
Norethindrone—Headache—Dexamethasone—psoriatic arthritis	8.18e-05	0.00101	CcSEcCtD
Norethindrone—Headache—Betamethasone—psoriatic arthritis	8.18e-05	0.00101	CcSEcCtD
Norethindrone—Asthenia—Prednisone—psoriatic arthritis	8.16e-05	0.00101	CcSEcCtD
Norethindrone—Pruritus—Prednisone—psoriatic arthritis	8.05e-05	0.000998	CcSEcCtD
Norethindrone—Gastrointestinal pain—Methotrexate—psoriatic arthritis	7.77e-05	0.000964	CcSEcCtD
Norethindrone—Nausea—Betamethasone—psoriatic arthritis	7.76e-05	0.000962	CcSEcCtD
Norethindrone—Nausea—Dexamethasone—psoriatic arthritis	7.76e-05	0.000962	CcSEcCtD
Norethindrone—Urticaria—Methotrexate—psoriatic arthritis	7.55e-05	0.000936	CcSEcCtD
Norethindrone—Dizziness—Prednisone—psoriatic arthritis	7.52e-05	0.000933	CcSEcCtD
Norethindrone—Abdominal pain—Methotrexate—psoriatic arthritis	7.51e-05	0.000932	CcSEcCtD
Norethindrone—Vomiting—Prednisone—psoriatic arthritis	7.23e-05	0.000897	CcSEcCtD
Norethindrone—Rash—Prednisone—psoriatic arthritis	7.17e-05	0.000889	CcSEcCtD
Norethindrone—Dermatitis—Prednisone—psoriatic arthritis	7.16e-05	0.000888	CcSEcCtD
Norethindrone—Headache—Prednisone—psoriatic arthritis	7.12e-05	0.000884	CcSEcCtD
Norethindrone—Hypersensitivity—Methotrexate—psoriatic arthritis	7e-05	0.000868	CcSEcCtD
Norethindrone—Asthenia—Methotrexate—psoriatic arthritis	6.82e-05	0.000846	CcSEcCtD
Norethindrone—Nausea—Prednisone—psoriatic arthritis	6.76e-05	0.000838	CcSEcCtD
Norethindrone—Pruritus—Methotrexate—psoriatic arthritis	6.72e-05	0.000834	CcSEcCtD
Norethindrone—Dizziness—Methotrexate—psoriatic arthritis	6.29e-05	0.000779	CcSEcCtD
Norethindrone—Vomiting—Methotrexate—psoriatic arthritis	6.04e-05	0.000749	CcSEcCtD
Norethindrone—Rash—Methotrexate—psoriatic arthritis	5.99e-05	0.000743	CcSEcCtD
Norethindrone—Dermatitis—Methotrexate—psoriatic arthritis	5.99e-05	0.000742	CcSEcCtD
Norethindrone—Headache—Methotrexate—psoriatic arthritis	5.95e-05	0.000738	CcSEcCtD
Norethindrone—Nausea—Methotrexate—psoriatic arthritis	5.65e-05	0.0007	CcSEcCtD
